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Epigeneticmechanismsare essential in regulatingneural progenitor cell self-renewal,with the chromatin-modifyingproteinEnhancer of
zeste homolog 2 (EZH2) emerging as a central player in promoting progenitor cell self-renewal during cortical development. Despite this,
how Ezh2 is itself regulated remains unclear. Here, we demonstrate that the transcription factor nuclear factor IB (NFIB) plays a key role
in this process.Nfib/mice exhibit an increased number of proliferative ventricular zone cells that express progenitor cellmarkers and
upregulation of EZH2 expression within the neocortex and hippocampus. NFIB binds to the Ezh2 promoter and overexpression of NFIB
represses Ezh2 transcription. Finally, key downstream targets of EZH2-mediated epigenetic repression are misregulated in Nfib/
mice. Collectively, these results suggest that the downregulation ofEzh2 transcription byNFIB is an important component of the process
of neural progenitor cell differentiation during cortical development.
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Introduction
Development of the brain requires a tightly controlled pro-
gram of progenitor cell proliferation and differentiation. Re-
cent advances have provided insights into how this is
controlled. For example, Notch signaling regulates both pro-
genitor self-renewal and gliogenesis (Kageyama et al., 2008).
Interestingly, recent evidence has implicated epigenetic con-
trol of transcription as being central to the self-renewal of
progenitor cells (Meaney and Ferguson-Smith, 2010). For in-
stance, the epigenetic mark induced by the polycomb repres-
sive complex 2 factor Enhancer of zeste homolog 2 (EZH2)
results in the widespread repression of regulatory genes re-
sponsible for lineage determination (Boyer et al., 2006, Lee et
al., 2006); therefore, EZH2 promotes progenitor cell self-
renewal. This finding has recently been extended to reveal a
role for EZH2 in maintaining cortical neural progenitor cell
identity (Sher et al., 2012). Moreover, ablation of Ezh2 at mid-
embryogenesis in the cerebral cortex results in precocious
neural progenitor cell differentiation (Pereira et al., 2010),
demonstrating that EZH2 regulates embryonic neural progen-
itor cell self-renewal. However, the transcriptional regulation
of Ezh2 during corticogenesis remains unclear.
The nuclear factor I (NFI) family of transcription factors
has been implicated in driving neural progenitor cell differen-
tiation. For example, NFIB is expressed by neural progenitor
cells and mice lacking this transcription factor exhibit deficits
in the production of postmitotic progeny within the develop-
ing telencephalon (Barry et al., 2008, Piper et al., 2009) and
spinal cord (Deneen et al., 2006). However, the underlying
process behind NFIB-mediated neural progenitor cell differ-
entiation remains unclear. To investigate this, we performed a
microarray screen within the hippocampus ofNfib/mice to
identify potential NFIB targets. This experiment identified
numerous chromatin-modifying genes as being upregulated
in the mutant, including Ezh2. Using analysis of Nfib/mice
and a suite of molecular and bioinformatics techniques, we
reveal here that Ezh2 is a target for transcriptional repression
by NFIB, suggesting that the deficits in neural progenitor cell
differentiation evident within Nfib/ mice (Barry et al.,
2008) may be due, at least in part, to the loss of NFIB-mediated
repression of this epigenetic regulator.
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Materials andMethods
Animals. Nfib/ and Nfib/ littermate mice of either sex (Steele-
Perkins et al., 2005) were used in this study with approval from the
University of Queensland animal ethics committee and experiments
were performed according to the AustralianCode of Practice for the Care
and Use of Animals for Scientific Purposes.
Immunohistochemistry. Embryos were drop-fixed in 4% paraformal-
dehyde (PFA) at embryonic day 14 (E14) or below or transcardially
perfusedwith 0.9% saline, followed by 4%PFA (E16, E18), andwere then
postfixed in 4% PFA at 4°C. Brains were paraffin embedded and sec-
tioned coronally at 6 m. Immunohistochemistry using the chromogen
3,3-diaminobenzidine was performed as described previously (Piper et
al., 2010) using the following rabbit polyclonal antibodies: anti-PAX6
(AB2237, 1/1000;Millipore), anti-SOX2 (catalog #2748, 1/1000; Cell Sig-
naling Technology), anti-EZH2 (catalog #39639, 1/1000; Active Motif),
and anti-phosphohistone H3 (catalog #06–570, 1/1000; Millipore).
Biotin-conjugated goat anti-rabbit IgG (BA-1000; Vector Laboratories)
secondary antibodies were used for chromogenic immunohistochemis-
try at 1/1000. Immunohistochemistry on paraffin sections using fluores-
cent secondary antibodies was performed as
described previously (Piper et al., 2010) using
the following antibodies: anti-PAX6 (1/100),
anti EZH2 (mouse monoclonal clone AC22,
1/50; Cell Signaling Technology), anti-NFIB
(rabbit polyclonal, HPA003956, 1/100; Sigma).
Goat-anti rabbit IgGAlexa Fluor 594 and goat-
anti-rabbit IgG Alexa Fluor 488 (Invitrogen)
were used for fluorescence immunohisto-
chemistry at 1/100.Nuclei were counterstained
with DAPI.
Quantification of ventricular zone width/hip-
pocampal cell counts. To measure the ventricu-
lar zone width in E14–E18 wild-type and
Nfib/ brains, 6 m paraffin sections were
hematoxylin stained and imaged with an up-
right microscope coupled to AxioVision soft-
ware (Zeiss). The width of the ventricular zone
was measured at three points along the hip-
pocampus for each section. Data for both wild-
type and knock-out hippocampi at each age
were then pooled for comparison of ventricu-
lar zone width. This analysis was further per-
formed at two different histological levels
along the rostrocaudal axis of the brain at each
age. For phosphohistone H3-, PAX6-, SOX2-
and EZH2-expressing cell counts, the total
number of immunopositive cells per 100min
the ventricular zone of the neocortex and hip-
pocampus of the wild-type and mutant was
counted. This analysis was conducted at three
pointswithin the hippocampus or neocortex in
each case, with data for each section then being
pooled for comparison of cell numbers. For the
analysis of EZH2/PAX6-expressing cells via
immunofluorescence, 6 m paraffin sections
were processed for immunofluorescence stain-
ing and imaged with an upright fluorescence
microscope coupled to AxioVision software
(Zeiss). The number of ventricular zone cells
per 100mwith the neocortex and hippocam-
pus expressing both EZH2 and PAX6 was then
quantified. This analysis was conducted at
three points within the hippocampus or neo-
cortex in each case, with data for each section
then being pooled for comparison of cell
numbers. For all analyses, six Nfib/ and
six Nfib/ brains were analyzed. Quantifi-
cation was performed blind to the genotype
of the sample. Statistical analyses were per-
Figure 1. Expansion of the ventricular zone in Nfib/ mice. A–D, Coronal sections of E16 Nfib/ and Nfib/ brains
stainedwithhematoxylin. The ventricular zone (VZ)was significantlywider in themutant (arrow inC,D) comparedwith controls
(arrowheads in A, B) at E16 and E18, but not at E14 (E). Sections were analyzed at rostral (A, C) and caudal (B, D) levels of the
hippocampus. F–I, PAX6 immunohistochemistry on coronal paraffin sections of E16 brains. The level of PAX6 expression in neural
progenitor cells was comparable between wild-type and mutant brains. However, there were significantly more cells expressing
PAX6 in themutant hippocampus at rostral (H ) and caudal (I ) levels comparedwith controls (F,G) at E16 and E18, but not E14 (J ).
r, Rostral; c, caudal. **p 0.01, t test. Scale bars: A–D, F–I, 600m; A-D, F -I, 250m.
Table 1. qPCR primer sequences used in this study
Gene Forward primer Reverse primer
Ink4A, exon 1b AGGTGCCTCAACGCCGAAG CTGGTCCAGGATTCCGGTGCGG
Ink4A, exon 2 ATGGGCAACGTTCACGTAGCAGC AGCGGTACACAAAGACCACCCA
Ink4B TAGCGCTCGAGCGTTCCCA TGTGGCAGAAATGGTCCTTC
Ink4C AGCCTTGGGGGAACGAGTT TGCAGCGCAGTCCTTCCAA
Ink4D GAGTTCTGATCCAGCTCTTG TCTTCCAGAAGCATAGTGGAT
Ezh2 TAGGGAGTGTTCAGTCACCA AACAGTTTCGTCTTCCACCAT
Pax6 ACGTATATCCCAGTTCTCAGA ATTCACTCCGCTGTGACTGT
Nestin GAAGTGGCTACATACAGGAC AGCTTCAGCTTGGGGTCAG
Hprt GCAGTACAGCCCCAAAATGG AACAAAGTCTGGCCTGTATCCAA
Olig1 ACAGGCAGCCACCTATCTCC GTTCAGCGAGCGGAGCTT
Id4 GAAGAGCAATCGTGAATCCAAC GTTCCCCGCCCTGTTATAATC
Dll1 TTCTCTGGCTTCAACTGTGAG CATTGTCCTCGCAGTACCTC
Prox1 GTCCGACATCTCACCTTATTCAG TCTGTTGAACTTCACGTCCG
Sox3 GCGACATGATCAGCATGTACC GCCCTGGTAGTGCTGGTG
Sox2 CCAATCCCATCCAAATTAACGC CTATACATGGTCCGATTCCCC
Hes5 CCAAGGAGAAAAACCGACTG AACTCCTGCTCCAGCAGCA
Gfap AGTGGTATCGGTCTAAGTTTG CGATAGTCGTTAGCTTCGTG
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formed using a two-tailed unpaired t test. Error bars represent the
SEM.
Birth-dating experiments. To analyze cell cycle exit, pregnant dams
were injected with 100 mg/kg 5-bromo-2-deoxyuridine (BrdU) at E15
and then with 100 mg/kg 5-ethynyl-2-deoxyuridine (EdU) 1 d later at
E16. Two hours after the EdU treatment, embryos were collected and
perfused before being processed for immunofluorescence staining using
an anti-BrdU antibody (G3G4, 1/10; Developmental Hybridoma Studies
Bank) and a EdU detection kit (Click-iT EdU cell proliferation kit; Life
Technologies). Sections were imaged with a confocal microscope (LSM
510 META; Zeiss) using Zen software (Zeiss). The number of cells posi-
tive for both BrdU and EdU was calculated as a proportion of the total
number of cells positive for BrdU. For this analysis, fiveNfib/ and five
Nfib/ brains were analyzed. Quantification was performed blind to
the genotype of the sample. Statistical analyses were performed using a
two-tailed unpaired t test. Error bars represent the SEM.
Hippocampal microarrays. Hippocampi from E16 wild-type (n  4)
and Nfib/ (n  3) mice were dissected, RNA was extracted, and
gene expression profiles were obtained as described previously (Piper
et al., 2010). Differential expression was determined by the one-way
ANOVA-Welch’s approximate t test without a multiple testing cor-
rection. A cutoff p-value of 0.05 was used for the mean difference
between wild-type and Nfib/ tissue. In addition, a 1.5-fold change
filter was imposed. Pathway analysis was performed using the DAVID
Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov/; Huang
da et al., 2009).
In silico promoter analysis. In silico promoter analysis was performed
using the binding motif TTGGC(N5)GCCAA. Full details of the scan-
ning method used and how we controlled for false discovery rate have
been described previously (Piper et al., 2010).
Quantitative real-time PCR. Cortical and hippocampal samples were
collected and snap frozen. RNA was extracted (RNeasy Micro Kit; Qia-
gen) and reverse transcription was performed. RNA was isolated from
cell lines in the same manner. Quantitative real-time PCR (qPCR) data
expression and analysis were performed as described previously (Piper et
al., 2010). For all qPCR analyses, RNA from at least three independent
replicates forNfib/ andNfib/mice or control and treated cells were
interrogated. All the samples were tested in triplicate and each experi-
ment was repeated a minimum of three times. The housekeeping gene
hypoxanthine phosphoribosyltransferase 1 was used to calculate relative
changes in gene expression level, which is presented asCt (Yuan et al.,
2006). Statistical analyses were performed using a one-sided Wilcoxon
rank-sum test. Because each test was based on a directional hypothesis,
the one-sided test was justified. When the sample size is 3, the minimum
p-value achievable from this nonparametric test is 0.05. Therefore, tests
marked as significant (*p 0.05) reflect the ranking of all samples in the
test group above (or below) samples in the control group. Error bars
represent the SD. Primer sequences can be found in Table 1.
ChIP. For ChIP, dorsal telencephalon was removed from E16Nfib/
and Nfib/ brains. The ChIP assay was performed using ChIP-IT Ex-
press kit (Active Motif) as per the manufacturer’s instructions. Antibod-
ies (ActiveMotif) usedwere anti-NFIB (#39091), anti-IgG (#53011), and
anti-H3K27me3 (#39155). Primer sequences can be found in Table 1.
Luciferase assay. The constructs used in the luciferase assay were a
full-length Nfib expression construct (Nfib pCAGIG-IRES-GFP), a lu-
ciferase construct containing 461 base pairs of the upstream promoter
region of themouse Ezh2 gene (Ezh2 Prom), and a luciferase construct in
which the 228 site had been mutated (Ezh2 mut Prom; the 228 se-
quence TTGTTCTTTTGCCAA was mutated to GAGATCTTTTGC-
CAA). DNA was transfected into Neuro2A cells using FuGene
(Promega). Cypridina luciferase was added to each transfection as a nor-
malization control. After 48 h, luciferase activity was measured using a
dual luciferase system (Switchgear Genomics). Within each experiment,
each treatment was replicated six times. Each experiment was also inde-
pendently replicated a minimum of three times. The pCAGIG vector
alone did not significantly alter Ezh2 promoter-driven luciferase activity
(data not shown). Statistical analyses were performed using ANOVA.
Error bars indicate the SD.
Electrophoretic mobility shift assay. Nuclear extracts were isolated from
the cortex of E18 brains and from COS cells overexpressing either NFIB
of a nonspecific transcription factor, AP2. The electrophoretic mobility
shift assay (EMSA) was performed using radiolabeled annealed oligonu-
cleotides containing a control NFI consensus site (Piper et al., 2010) or
Ezh2 consensus sites from our bioinformatics screen. EMSA reactions
were performed as described previously using 1 g of nuclear extract
(Piper et al., 2010). Oligonucleotide sequences were as follows: NFI con-
trol, 5-ggTTTTGGATTGAAGCCAATATGATAA-3 (upper strand),
5-ggTTATCATATTGGCTTCAATCCAAAA-3 (lower strand); Ezh2-
294, 5-ggCCGGGTTGGCGGGACCCGAAC-3 (upper strand), 5-
ggCCGGGTTCGGGTCCCGCCAAC-3 (lower strand); Ezh2-294 mut,
5-ggCCGGGCCGGCGGGACCCGCCC-3 (upper strand), 5-ggC-
CGGGGGCGGGTCCCGCCGGC-3 (lower strand); Ezh2-228
5-ggCCGGGTTGTTCTTTTGCCAAC-3 (upper strand), 5-
ggGGCCGGGTTGGCAAAAGAACAAC-3 (lower strand); Ezh2
228 mut 5-ggCCGGGTTGTTCTTTTGTCTCC-3 (upper strand),
5-ggCCGGGGAGACAAAAGAACAAC-3 (lower strand). Super-
shift assays were performed with either an anti-NFIB antibody (cata-
log #39091; Active Motif), and anti-HA antibody (catalog #H9658;
Sigma) or a control IgG antibody (normal rabbit IgG, catalog #2729S;
Cell Signaling Technology). Additional bases used to generate 5
overhangs for end fill are indicated in lower case.
Cell culture. E14 primary cortical cells were isolated and 1 106 cells
were electroporated with 10 g of plasmid (Neon Transfection system;
Invitrogen). The plasmids used were Nfib pCAGIG-IRES-GFP,
pCAGIG-IRES-GFP vector control,Ezh2 shRNA (OrigeneTechnologies;
Table 2. Selected genes downregulated in the Nfibmutant hippocampus at E16
Common Fold change GenBank
Robo4 1.58 NM_028783
Sema3a 1.66 NM_009152.2
Prox1 2.03 NM_008937.2
Slc1a1 2.25 NM_009199.2
Slc5a1 2.26 NM_019810.3
Gdnf 2.32 NM_010275.2
Sema4f 2.35 NM_011350
Lhx5 2.68 NM_008499.4
Scn3a 2.86 NM_018732.1
Gfap 3.87 NM_010277.2
Gdf10 5.34 NM_145741.2
Olig1 5.58 NM_016968.4
Islet 1 6.23 NM_021459.3
A cutoff p-value of 0.05 was used for the mean difference between wild-type and Nfib knock-out hippocampal
tissue. In addition, a 1.5-fold change filter was imposed on the genes from the ANOVA dataset.
Table 3. Selected genes upregulated in the Nfibmutant hippocampus at E16
Common Fold change Genbank
Gli2 1.50 NM_001081125.1
Smarcd3 1.60 NM025891.3
Ezh2 1.61 NM_007971.1
Bmi1 1.64 NM_007552.4
Pou2f2 1.71 NM_011138.1
Pou2f1 1.87 NM_198933.2
Sox3 1.96 NM_009237.1
Nodal 2.08 NM_013611.3
Mll3 2.08 NM_001081383.1
Sox2 2.25 NM_011443.3
Eya1 2.26 NM_010164.2
Noggin 2.33 NM_008711.1
Hes5 2.34 NM_010419.4
Id4 2.35 NM_031166.2
Dll1 2.60 NM_007865.2
Gli3 2.61 NM_008130.2
Pax6 4.30 NM_013627
A cutoff p-value of 0.05 was used for the mean difference between wild-type and Nfib knock-out hippocampal
tissue. In addition, a 1.5-fold change filter was imposed on the genes from the ANOVA dataset.
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the vector encoding this shRNA carries a RFP cassette for selection of
transfected cells), Nfib siRNA (Invitrogen; the vector encoding this
siRNA carries a GFP cassette for selection of transfected cells), and non-
specific shRNAs and siRNAs. The Ezh2 shRNA caused a significant de-
crease in Ezh2 mRNA levels 48 h after transfection (relative transcript
levels of Ezh2/Hprt: control 2.02 	 0.77, Ezh2 shRNA 0.68 	 0.07, p 
0.05, Wilcoxon rank-sum test). TheNfib siRNA also caused a significant
decrease in Nfib mRNA levels (relative transcript levels of Nfib/Hprt:
control 20.3 	 0.84, Nfib siRNA 8.73 	 1.78, p  0.05, Wilcoxon
rank-sum test). The control nonspecific shRNAs and siRNAs did not
alter endogenous gene transcript levels either individually or in com-
bination (data not shown). The control data represented in Figure 7,
C and D, represent cells treated with both the nonspecific shRNA and
siRNA controls. After electroporation, the cells were immediately
returned to growth medium (HEPES-buffered minimal essential me-
dium  2% goat serum) and cultured on fibronectin/lysine-coated
Figure2. Ezh2 is a target for transcriptional repressionbyNFIB.Microarray analysiswasperformedonE16Nfib/ andNfib/hippocampal tissue. Geneswere annotatedusing the Functional
Annotation Tool of DAVID, revealing key biological processes that were upregulated (A) and downregulated (B) in the hippocampus of Nfib/ mice. Processes associated with chromatin
modificationwere significantly enriched in themutantmice. Key examples of transcripts upregulated (C) or downregulated (D) inNfib/hippocampal tissue are also shownand includemembers
of thepolycomb repressive complexes suchas Ezh2andBmi,which arebothupregulated in themutant.E, An in silico screen for predictedNFI-binding sites identified conservedpotential NFI-binding
sites within the proximal promoter of the mouse Ezh2 gene and the human EZH2 gene. We report the position of potential sites in bases relative to the transcription start site (TSS) The genomic
coordinates (mm9, 1-based) of the two sites inmouse are (228) chr6:47545257–47545271and (294) chr6:47545323–47545337.F, qPCR revealed significantly higher Ezh2mRNA levels in the
cortex (E14, E16) and hippocampus (E16) of Nfib/mice. *p 0.05, Wilcoxon rank-sum test.
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six-well plates. After up to 5 d in culture, cells were FACS sorted for
GFP-positive (pCAGIG vectors, Nfib and control siRNA), RFP-
positive (Ezh2 and control shRNA), or GFP- and RFP-positive (both
Ezh2 and Nfib knock-down plasmids) transfectants, and the RNA
isolated for cDNA synthesis and qPCR analysis. This experiment was
also conducted in Neuro2A cells with the following modifications:
3  10 5 cells were transfected with the knock-down constructs using
FuGene (Promega) and were sorted via FACS 2 d after transfection.
RNA was subsequently isolated using an RNeasy micro kit (Qiagen).
Results
Chromatin-modifying factors are upregulated in the
hippocampus ofNfib/mice
Expression of NFIB within ventricular zone neural progenitor
cells of the telencephalon is initiated at 
E12/E13 and be-
comes prominent within these cells by E15 (Plachez et al.,
2008). Embryonic Nfib/ mice exhibit subtle delays in neu-
ronal differentiation and severe delays in astrogliogenesis,
leading to aberrant hippocampal morphology (Barry et al.,
2008). Analysis of the hippocampus of E14, E16, and E18
Nfib/ mice revealed that mutant mice also exhibit a signif-
icant increase in ventricular zone size at E16 and E18, but not
at E14 (Fig. 1A–E). This is coupled with the presence of signif-
icantly more cells expressing the progenitor-specific marker
PAX6 compared with wild-type littermate controls at E16 and
E18 (Fig. 1F–J ). Moreover, this phenotype was observed at
different positions along the rostrocaudal axis of the mutant
brain (Fig. 1). Collectively, these findings are indicative of
reduced progenitor cell differentiation within the hippocam-
pus of Nfib/ mice.
To determine themechanism underly-
ing Nfib-mediated differentiation of pro-
genitor cells, we performed a microarray
study on hippocampi from E16 Nfib/
andNfib/mice. This analysis identified
5000 genes as being differentially ex-
pressed within the hippocampus of the
mutant mice using a significance level of
p  0.05 via ANOVA and a fold-change
cutoff of 1.5. Genes involved in neuronal
and glial differentiation, such as Prox1,
Gfap, andOlig1, were downregulated (Ta-
ble 2), whereas many genes linked to pro-
genitor cell self-renewal, such as Sox2,
Dll1,Hes5, and Id4, were upregulated (Ta-
ble 3). Validation of these findings was
done by performing qPCR onmRNA iso-
lated from independent wild-type and
mutant hippocampal samples, revealing
significant (p  0.01, t test) downregu-
lation of Prox1 (1.7-fold decrease),
Olig1 (1.8-fold decrease), and Gfap (12-
fold decrease) in samples from the mu-
tant hippocampi. Similarly, significant
upregulation (p  0.05, t test) of Dll1,
Sox2, and Sox3 (each exhibited a 1.3-
fold increase), as well as Hes5 and Id4
(each exhibited a 1.7-fold increase), was
observed in samples from the mutant
hippocampi.
Interestingly, functional annotation of
those genes upregulated in the hippocam-
pus of the mutant mice using the DAVID
Bioinformatics Resource showed that
processes involved in the modulation of chromatin structure
were highly enriched in themutant. These included the processes
of chromosome reorganization, chromatin organization, and
chromatin modification (Fig. 2A,B), suggesting that NFIB may
influence chromatin structure during development. Analysis of
transcripts upregulated in the hippocampus of Nfib/ mice
provided further insight into this, with many genes involved in
chromosome reorganization and chromatin modification being
significantly upregulated in the mutant, including members of
the polycomb repressive complexes 1 and 2, such asEzh2 andBmi
(Fig. 2C,D).
Ezh2 is upregulated in the ventricular zone ofNfib/mice
Our array findings suggested that NFIB may promote the differ-
entiation of neural progenitor cells via the transcriptional regu-
lation of genes encoding epigenetic regulators. Given the recent
identification of the roles played by polycomb repressive complex
members in cortical progenitor cell self-renewal (Hirabayashi et
al., 2009, Pereira et al., 2010, Sher et al., 2012), we focused on
these factors as potential NFIB targets. To identify direct targets
of NFIB, we first used an in silico screen searching for the high-
affinity NFI-binding site (TTGGC(N5)GCCAA) in the 2 kb re-
gion upstream of the transcription start site of polycomb
repressive complex genes, including Ezh2, Eed, Bmi, Cbx2, Cbx3,
Suz12, and Ring1b. This screen identified Ezh2 as having two
putative, highly conserved NFI-binding motifs in its basal pro-
moter (Fig. 2E), suggesting that repression of Ezh2 transcription
may underlie NFIB-mediated neural progenitor cell differentia-
tion. Analysis of independent hippocampal samples at E16 with
Figure 3. Coexpression of NFIB and EZH2 in neural progenitor cells of the forebrain. Coimmunofluorescence staining of E14 (A)
and E16 (B) wild-type coronal brain sections at the level of the hippocampus revealing the expression of NFIB (red) and EZH2
(green). A and B are low-power images, with DAPI-stained nuclei (blue) revealing the morphology of the selected sections.
Higher-magnification images are taken from the boxed regions in A andB, respectively. At E14, neural progenitor cells within the
ventricular zone of the neocortex (A) and hippocampus (A) coexpress NFIB and EZH2. Similarly, neocortical (B) and hippocam-
pal (B) neural progenitor cells express both of these factors at E16. Scale bars: A, B, 250m; A, A, B, B, 40m.
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qPCR confirmed the upregulation of Ezh2mRNA levels in the
hippocampus of Nfib/ mice (Fig. 2F ). Moreover, Ezh2 lev-
els were also upregulated in the mutant cortex at E14 and E16
(Fig. 2F ).
Previous studies have indicated that neural progenitor cells
within the ventricular zone of the forebrain express NFIB (Pla-
chez et al., 2008) and EZH2 (Hirabayashi et al., 2009). Coimmu-
nofluorescence staining performed on paraffin sections fromE14
and E16 wild-type brains revealed coexpression of these markers
within the hippocampal and neocortical ventricular zone, indi-
cating that NFIB and EZH2 are coexpressed in neural progenitor
cells (Fig. 3). The increased number of neural progenitor cells in
the mutant expressing PAX6 (Fig. 1) suggested that the differen-
tiation of these cells was delayed in Nfib/ mice. Further evi-
dence to support this came from analysis of the Nfib mutant
brains using immunohistochemical detection of the progenitor-
cell-specific marker SOX2 (Fig. 4A,B) and the mitotic marker
phosphohistone H3 (PHH3; Fig. 4C,D) at E16. This revealed sig-
nificantly more dividing progenitor cells in the neocortical and
hippocampal ventricular zones of Nfib/ mice (Fig. 4E). Fur-
thermore, immunohistochemistry with the chromogen DAB re-
vealed that there were more EZH2-expressing neural progenitor
cells (as defined by their elongated nuclei and proximity to the
ventricular zone) in the neocortical and hippocampal ventricular
zone of the mutant at this age (Fig. 4E and data not shown). We
also analyzed cell cycle exit within neural progenitor cells by in-
jecting pregnant Nfib/ dams with BrdU at E15 and then with
EdU at E16 2 h before being killed under the rationale that
Nfib/mice would exhibit reduced numbers of neural progen-
itor cells exiting the cell cycle. Indeed, quantification of cells
within the hippocampus of knock-out animals confirmed the
presence of significantlymore cells that were both BrdU and EdU
positive as a proportion of the number of total BrdU-positive
cells than in the wild-type controls (Fig. 4F), suggestive of re-
duced cell cycle exit by progenitors within themutant hippocam-
pal ventricular zone. Critically, coimmunofluorescence labeling
with antibodies against EZH2 and PAX6 revealed that there were
significantly more PAX6-positive neural progenitor cells in the
neocortical and hippocampal ventricular zone of the mutant
mice expressing EZH2 than within wild-type littermate controls
(Fig. 5). Collectively, these data suggest that NFIB represses Ezh2
expression and that, in the absence of NFIB, EZH2 levels are
elevated and there are increased numbers of proliferating cells
within the cortical ventricular zone, so differentiation is delayed.
NFIB is able to regulate Ezh2-promoter driven
transcriptional activity
The presence of the NFI-binding motif in the promoter of the
Ezh2 gene is suggestive of NFIB being able to control the tran-
scription of this gene during development. To investigate this, we
first investigated whether NFIB could bind to these predicted
sites within the Ezh2 promoter. Using EMSA, we determined that
a protein from nuclear extracts derived from embryonic cortical
tissue bound to one of the two predicted NFI-binding sites
(228; Fig. 2E). Supershifting of the 228 probe with an anti-
NFIB antibody indicated that this protein complex contained
Figure 4. Increased number of proliferating neural progenitor cells in the forebrain ofNfib/mice.A–D, Low-magnification images of coronal sections of E16 hippocampi showing expression
of SOX2 (A,B) andphosphohistoneH3 (PHH3;C,D). Higher-magnification images of theneocortical ventricular zone (identifiedwithprimemarks) andhippocampal ventricular zone (identifiedwith
double prime marks) are shown to the right of each low-power image. In the panels showing SOX2 (A, B), the ventricular zone is bounded by the dashed lines. There were significantly more cells
expressing SOX2, PHH3 (PHH3-expressing cells in the ventricular zone are shownwith arrows in C, C, D, and D), and EZH2 in the neocortical and hippocampal ventricular zone of the mutant
at this age compared with the control (E). F, Proliferating cells were labeled with BrdU at E15 and then with EdU at E16 (2 h before kill) to assess cell cycle exit. The number of cells positive for both
BrdU and EdU as a proportion of the total number of BrdU-positive cells was quantified and this proportionwas significantly higher within the hippocampus ofNfib/mice, indicative of reduced
cell cycle exit within these mice. *p 0.05, **p 0.01, t test. VZ, Ventricular zone. Scale bars: A–D, 250m; A A, B, B, C, C, D, D, 40m.
2926 • J. Neurosci., February 19, 2014 • 34(8):2921–2930 Piper, Barry et al. • NFIB Represses Ezh2 to Regulate Corticogenesis
NFIB (Fig. 6A). A supershift experiment performed with a con-
trol antibody that does not recognize NFIB (normal rabbit IgG)
did not produce a band with increased electrophoretic mobility
(Fig. 6B), reflecting the specificity of this supershift. We next
repeated the EMSA experiment using nuclear extracts derived
from COS cells expressing an HA-tagged NFIB construct or a
tagged nonspecific transcription factor (HA-tagged AP2 con-
struct). Importantly, only the nuclear extract from the NFIB-
expressing cells exhibited a supershift when an anti-HA antibody
was included in the binding reaction, which is further indicative
of the specificity of NFIB binding to the228 sequence (Fig. 6C).
We also performed an EMSAwith a probe in which the228 site
had beenmutated. Themutated oligonucleotide did not exhibit a
band at the same size as thewild-type228 probe, indicating that
NFIB could no longer bind this sequence (Fig. 6D).
Next, we performed ChIP on wild-type embryonic cortical
samples and observed enrichment of NFIB binding to the Ezh2
promoter region containing this predicted NFI-binding site, in-
dicating that NFIB binds to the Ezh2 promoter in vivo (Fig. 6E).
Finally, we used a reporter gene assay (luciferase assay) to deter-
mine whether NFIB could regulate Ezh2 promoter-driven gene
expression. A 461 base pair region of the mouse Ezh2 promoter
that contained the putative NFI motif at 228 was cloned up-
stream of the luciferase gene. Cotransfection of this construct
with an Nfib expression plasmid within Neuro2A cells revealed
that NFIB is able to repress Ezh2 promoter-driven transcription
in vitro (Fig. 6F). Importantly, this repression was abolished
when the NFI-binding site at 228 in the Ezh2 promoter was
mutated (Fig. 6F). Together, these findings reveal that NFIB oc-
cupies the endogenous Ezh2 promoter in vivo and can repress
Ezh2 promoter-driven gene expression.
NFIB represses Ezh2 expression in primary cortical cells
Thesemolecular approaches, along with our histological analyses
on Nfib/ mice, led us to hypothesize that NFIB mediates the
repression of Ezh2 transcription. To test this hypothesis, we
transfected a Nfib expression construct (carrying an IRES-GFP
cassette) into E14 cortical progenitor cells. After 24, 48, or 96 h in
culture in vitro, transfected cells were isolated by FACS. GFP-
positive cortical cells showed upregulation of Nfib at all time
points examined compared with cells transfected with a vector-
only control plasmid (data not shown). At 24 and 48 h after
transfection, Ezh2 transcript levels were significantly reduced in
GFP-positive cortical cells, although levels at 96 h were not sig-
nificantly different from controls (Fig. 7A).
As a member of the polycomb repressive complex 2, EZH2
mediates the trimethylation of lysine residue 27 on histone H3
(H3K27me3) via its SET domain, culminating in epigenetic re-
pression of target genes (Cao et al., 2002). We hypothesized that
downstream targets of EZH2, such as the Ink4A locus, a known
target for EZH2-mediated epigenetic repression (Agherbi et al.,
2009), would exhibit elevated levels of epigenetic repression. To
address this, we used an antibody specific for H3K27me3 and
revealed significantly enriched levels of H3K27me3 at exons 1
and 2 of the Ink4A locus in Nfib/ cortical tissue (Fig. 7B),
consistent with the elevated levels of Ezh2 in these mice. Recent
reports have suggested that the repression of Ink4A results in
compensatory increases in the expression of other Ink4 family
members (Ramsey et al., 2007, Wiedemeyer et al., 2008). Our
data support these findings, demonstrating that the proximal
promoter regions of the Ink4B (p15, Cdkn2b), Ink4C (p18,
Cdkn2c), and Ink4D (p19, Cdkn2d) loci carried significantly re-
duced H3K27me3 epigenetic marks, as shown by ChIP with the
H3K27me3 antibody (Fig. 7B). Although these findings provide
further evidence for a feedback circuit among Ink4 genes (Wie-
demeyer et al., 2008), the mechanisms governing the differential
regulation of chromatin modification between family members
remains unresolved. Collectively, these data show that NFIB re-
presses Ezh2 expression in cortical cells in vitro and that the ele-
vation of EZH2 expression inNfib/mice promotes epigenetic
changes to a key downstream target gene in vivo.
Finally, we used transient depletion of Ezh2 and/or Nfib in
Neuro2A cells to analyze the consequence of the reduction of
Ezh2 mRNA in cortical cells that have reduced Nfib levels. In
cells expressing Nfib siRNA alone, mRNA levels of Pax6 were
significantly increased. However, when Ezh2 and Nfib were
reduced concurrently, the level of Pax6mRNA was not signif-
icantly different from that of the control (Fig. 7C). A similar
outcome was observed with the mRNA of a second progenitor
cell marker, nestin (Fig. 7C). These findings were also repli-
cated when we performed this experiment within cultured E14
cortical cells (Fig. 7D), demonstrating that a reduction of Ezh2
expression is sufficient to restore the balance of progenitor cell
marker expression induced by depletion of Nfib.
Figure 5. Increased number of EHZ2-expressing neural progenitor cells in the forebrain of
Nfib/mice. Coimmunofluorescence labeling of E16wild-type (A) and Nfib/ (B) coronal
brain sections at the level of the hippocampus. A and B are low-power images, with DAPI-
stained nuclei (blue) revealing the morphology of the selected sections. Higher-magnification
images are taken from the boxed regions in A and B, respectively. In the wild-type, cells within
the neocortical (A) and hippocampal (A) ventricular zone express both the neural progenitor
cell marker PAX6 and EZH2 (the ventricular in each case is bounded by dashed lines). In the
mutant, however (B), there are significantly more cells within the ventricular zone of the neo-
cortex (B) and hippocampus (B) expressing both PAX6 and EZH2 (C). **p 0.01, t test. VZ,
Ventricular zone. Scale bars: A, B, 250m; A A, B, B, 40m.
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Discussion
The balance between self-renewal and differentiation ofmultipo-
tent progenitor cells within the embryonic cerebral cortex is cen-
tral to the development of the mature brain. Epigenetic
mechanisms play a critical role in this process, regulating the
generation of neuronal and glial lineages from progenitor cells
within the developing cortex (Meaney and Ferguson-Smith,
2010). For example, the polycomb group proteins RING1B and
EZH2 limit the neurogenic competence of cortical neural pro-
genitors, in part via the epigenetic repression of the proneural
target genes such as neurogenin 1 (Hirabayashi et al., 2009),
whereas ablation of Ezh2 culminates in a shift from self-renewal
toward differentiation within cortical progenitors (Pereira et al.,
2010). These data indicate that a central role of EZH2 during
telencephalic development is to promote progenitor cell self-
renewal. Furthermore, a recent finding revealed that the chro-
modomain helicase Chd4 plays a key role in regulating
polycomb-mediated suppression of Gfap expression via interac-
tion with EZH2 (Sparmann et al., 2013). However, our under-
standing of how Ezh2 activity is transcriptionally regulated
during development and how this affects the differentiation of
neural progenitor cells remains unclear.
In this study, we reveal that NFIB regulates the differentiation
of embryonic neural progenitor cells in part via repression of
Ezh2 transcription. Indeed, the NFI proteins are emerging as piv-
otal components of the transcriptional program driving neural
progenitor cell differentiation. For instance, NFIs have been
shown to activate glial-specific (Cebolla and Vallejo, 2006) and
neuronal-specific (Wang et al., 2010, Wang et al., 2007) gene
expression directly andNfi-knock-out mice exhibit reduced em-
Figure 6. NFIB binds to the promoter of Ezh2 and represses Ezh2 promoter-driven reporter gene activity. A–D, Results of EMSA. A, E18 mouse brain nuclear extracts were incubated with
radiolabeled probes for the NFI control (lanes 1–2) and the294 (lanes 3–4) or the228 (lanes 5–6) consensus sites. Binding reactions included anti-NFIB antibodies where indicated. A factor
from the nuclear extract bound specifically to the control and the228 probes. This complex (*)was supershifted (SS) in the presence of the anti-NFIB antibody. FP, Free probe.B, E18mouse brain
nuclear extracts were incubated with radiolabeled probes for the NFI control (lanes 1–3) or the228 (lanes 4–6) consensus sites. A factor from the nuclear extract bound specifically to these
probes. This complex (*)was supershifted in the presence of the anti-NFIB antibody, but not an IgG control antibody. C, Nuclear extracts fromCOS cells expressing the transcription factor AP2 or NFIB
(bothofwhich carry anHA tag)were incubatedwith radiolabeledprobes for theNFI control (lanes 1–4)or the228 (lanes 5–8) consensus sites. A factor fromthenuclear extracts bound specifically
to these probes (*). Only the nuclear extract from the COS cells expressing the HA-taggedNFIB construct exhibited a supershift when an anti-HA antibodywas included in the binding reaction (lanes
4 and 8). D, E18 mouse brain nuclear extracts were incubated with radiolabeled probes for the NFI control (lane 1) and the294 (lane 2), mutated294 sequence (lane 3),228 (lane 4), or
mutated228 (lane 5) consensus sites. A factor from the nuclear extract bound specifically to the control and the228 probes (*). A band at the level of the NFI control was no longer observed
when the NFI consensus site within the228 probewasmutated (lane 5). A bandwas seen at a lower level (arrow), likely indicating that we had created a sequence bound by a different factor. E,
ChIP assays were conducted on tissue isolated from whole E16 wild-type cortex. DNA fragments immunoprecipitated with control IgG or anti-NFIB antibodies were analyzed by PCR with primers
specifically designed to encompass the predicted NFI-binding sites within the Ezh2 promoter. An adjacent region of the Ezh2 promoter lacking a defined NFI-binding site was used as a control.
Enrichment of NFIB binding was observed in the promoter region containing the predicted NFI-binding sites. F, Luciferase reporter gene assay performed in Neuro2A cells. NFIB expression (Nfib
pCAGIG) elicited no luciferase activity, whereas transfection of an Ezh2 promoter-driven luciferase reporter construct elicited reporter gene induction. Cotransfection of Nfib pCAGIG with the Ezh2
promoter construct resulted in a significantly reduced level of luciferase activity.Mutationof theNFI-binding site at228within the Ezh2promoter abolishedNFIB-mediated repressionof luciferase
activity. ns, Not significant. *p 0.05, ANOVA.
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bryonic astrocytic formation (Barry et al., 2008, das das Neves et
al., 1999, Deneen et al., 2006, Heng et al., 2014, Piper et al., 2010,
Piper et al., 2011) and delays in neuronal development (Wang et
al., 2010, Wang et al., 2007). Interestingly, NFIA has also been
implicated in epigenetic control of gene expression, albeit via a
differentmechanism from that proposed in this study. Binding of
NFIA to the Gfap promoter results in the dissociation of DNA
methyltransferase 1 from this locus, leading to reduced levels of
repressive methylation at the basal Gfap promoter (Namihira et
al., 2009).
Our findings are significant in that, although we are begin-
ning to unravel the genetic hierarchy downstream of epige-
netic chromatin-modifying proteins such as EZH2, our
understanding of the transcriptional control of these genes
remains limited. Interestingly, our microarray findings re-
vealed that proteins that function in epigenetic regulation
were highly represented in the list of upregulated genes in the
Nfib/ hippocampus. We focused on Ezh2 due to the pres-
ence of conserved, putative NFI-binding sites within the Ezh2
promoter and the previously reported role for EZH2 in the
regulation of neural progenitor cell self-renewal. Interestingly,
we also identified potential NFI-binding sites in the promoters
of Eed, Bmi1, and Cbx2, suggesting that these genes may also
be regulatory targets of NFIB during de-
velopment. Furthermore, although we
did not identify NFI-binding sites in the
proximal promoters of other genes
within the polycomb repressive com-
plexes, we cannot rule out NFIB-
mediated transcriptional control of
these genes from this dataset. Further
analysis of NFI-binding sites within the
whole genome, including intronic and
enhancer regions, followed by in vitro
and in vivo validation, will provide a
means to assess the extent of direct reg-
ulatory control of these genes by NFIB.
Future studies aimed at identifying a
genome-wide epigenetic profile in the
Nfib/ cortex may provide a broader
understanding of those candidate genes
undergoing enhanced epigenetic silenc-
ing in the absence of Nfib during
development.
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